Concept explainers
CASE STUDY | Art inspires learning
A genetics student visiting a museum saw a painting by Goya showing a woman with a newborn baby in her lap that had very short arms and legs along with some facial abnormalities. Wondering whether this condition might be a genetic disorder, the student went online, learning that the baby might have Roberts syndrome (RBS), a rare autosomal recessive trait. She read that cells in RBS have mitotic errors, including the premature separation of centromeres and other heterochromatic regions of homologs in metaphase instead of anaphase. As a result, metaphase chromosomes have a rigid or “railroad track” appearance. RBS has been shown to be caused by mutant alleles of the ESCO2 gene, which functions during cell division.
The student wrote a list of questions to investigate in an attempt to better understand this condition. How would you answer these questions?
What do centromeres and other heterochromatic regions have in common that might cause this appearance?
Case summary:
On visiting the museum, the genetics student noticed a painting made by the Goya. In the painting, a woman was drawn with the baby in her lap, the baby had very little arms and legs along with some facial abnormalities. The student wonders about the condition, that it might be a genetic disorder. Through the online research, he reached to the conclusion that the baby might have RBS (Roberts syndrome), it is a rare autosomal recessive trait. In this disorder, the cells suffered from the mitotic errors that include the early separation of the centromeres and also heterochromatic regions of the homologous chromosomes at the stage of the metaphase instead of anaphase. RBS is caused by the mutated alleles of the ESCO2 gene, that has a role in the cell division.
Characters in the case:
A genetics student and a painting of a baby withvery little arms and legs along with some facial abnormalities.
Adequate information:
Facts of the case that brings in major impact are the limbs and facial abnormality in the painting of a baby, which a genetic student interpreted as RBS (Roberts syndrome) that iscaused by the mutated alleles of the ESCO2 gene.
To determine:
The common thing in between the centromere and other heterochromatic regions that causes the abnormal appearance in the RBS.
Given information:
The newborn baby had many facial abnormalities and also the length of the arms and legs are comparatively short.
Explanation of Solution
Roberts syndrome is the extremely rare genetic disorder that is due to the disrupted cell division that leads to the malformation of the bones, face, arms, legs and the skull. On chromosome number 8, a mutation in the gene ESCO2 results in the Roberts syndrome.
In a normal individual, during the cell division the copied chromosomes attach themselves to the centromeres but in RBS the newly formed chromosomes are not frequently attached themselves with the centromeres. Due to which the proper alignment of the chromosomes does not takes place.
PCS (premature chromosomal separation) occurs in the RBS as the chromosomes that are supposed to separate at the anaphase stage separates at the metaphase stage. Another chromosomal abnormality is that HR (heterochromatin repulsion), chromosomes that are having the HR experiences the heterochromatin separation at the metaphase stage. Both of these chromosomal abnormalities displays a railroad track appearance as they both lack the primary constriction and also the heterochromatin repulsion.
Therefore, it can be concluded that centromeres and the other heterochromatin regions both are separated at the metaphase stage that could cause the abnormality in the baby having RBS.
Want to see more full solutions like this?
Chapter 11 Solutions
Essentials of Genetics (9th Edition) - Standalone book
- Base on your knowledge of DNA, chromosomes and epigenetics and upon examining the picture below, name two epigenetic factors and at least one non-epigenetic factor present on this picture. [HINT: which of the factors shown on the picture do you expect to change based on the interactions with an environment and which you expect unchanged?] Methyl Group DNA Chromatin Epigenetic Factor Histone Histone Tails Chromosomearrow_forwardA patient who has been diagnosed with cancer has been given a blood test in order for their doctors to investigate their genetic code. What information from the test would help confirm the patient's cancer diagnosis? O Data indicating somatic cell production is being inhibited by the patient's cancer cells Data indicating there is a genetic mutation in a protein controlling the patient's cell's cycle Data indicating gametes are becoming diploid cells due to the introduction of cancerous cells. O Data indicating that cells are increasing their chromosome number due to the occurrence of cancer cells. Next 8:29 AM Previous へロ ) 4/6/2021 12016000076202 F12 Home F10 F11 F8 F9 prisc F6 F7 F5 F3 F4 F1 F2 & #3 $ 7 3 4 * 00arrow_forward1. Assume that figure (A) represents a normal karyotype of this animal. What is the diploid number of thisanimal? 2.Cell (A) contains 3.1 billion (3.1 x 109) base pairs of DNA. Each nucleosome has about 200 bp of DNAwrapped around the histone core.a. What is the maximum number of nucleosomes that can be present in the cell?b. What is the maximum number of H2A histone protein molecules that can be present in the cell?arrow_forward
- Solid Wire Models of Cell Division 1- Get four solid wires, 2 long (1 green and 1 red) and two short (1 green and 1 red). This will represent the chromatin in a cell. The wires of the same length are homologous. Red wires will represent the chromatin from the female parent while green wires represent the chromatin from the male parent. Label the chromatin as follows: long green- 1a short green- 2c long red- 1b short red- 2d 2- Let the cell pass S phase. Replicate or duplicate each chromatin fiber. Do this by getting another set of wire identical to the original set. Label as before. 3- Combine the replicated chromatin fiber using masking tape. The tape will also mark the position of the centromere. For the short chromatin, place the tape exactly at the middle while for the long chromatin, place it at a point % from the end of the wire. 4- Assume that the chromosome fibers are folded. This will now represent the chromosomes. OR Varrow_forwardLS1-4 Dolly the Sheep, was born in 1996 in Scotland. She was the first mammal ever cloned from a single cell. The scientist created Dolly in a lab using three mothers: Sheep A provided the egg, Sheep B provided the DNA, and Sheep C carried the embryo to term. During this process, Dolly's cells went through several phases of mitotic growth. Which statement represents the processes of both the somatic cell cycle and cell differentiation? A student scratches his arm causing skin cells to fall off. These cells are soon replaced by identical ones and the student does not notice. A baby is growing in its mother's womb from a tiny ball of cells to an 8lb baby boy. Hematopoietic stem cells (HSCS) turn into different blood cells in a girl's hip bone. O A teenager undergoes a growth spurt one summer.arrow_forwardGenes are not always active in cells. The cell has evolved to edit its chromatin state in accord with the energy needs of the cell and organism. What are these two kinds of chromatin called and how does chromatin modeling work in cells? Name four of the known families of chromatin remodeling complexes enzyme complexes that act directly on DNA to alter nucleosome composition in transcribed regions.arrow_forward
- Who Owns Your Genome? John Moore, an engineer working on the Alaska oil pipeline, was diagnosed in the mid-1970s with a rare and fatal form of cancer known as hairy cell leukemia. This disease causes overproduction of one type of white blood cell known as a T lymphocyte. Moore went to the UCLA Medical Center for treatment and was examined by Dr. David Golde, who recommended that Moores spleen be removed in an attempt to slow down or stop the cancer. For the next 8 years, John Moore returned to UCLA for checkups. Unknown to Moore, Dr. Golde and his research assistant applied for and received a patent on a cell line and products of that cell line derived from Moores spleen. The cell line, named Mo, produced a protein that stimulates the growth of two types of blood cells that are important in identifying and killing cancer cells. Arrangements were made with Genetics Institute, a small start-up company, and then Sandoz Pharmaceuticals, to develop the cell line and produce the growth-stimulating protein. Moore found out about the cell line and its related patents and filed suit to claim ownership of his cells and asked for a share of the profits derived from the sale of the cells or products from the cells. Eventually, the case went through three courts, and in July 1990n years after the case beganthe California Supreme Court ruled that patients such as John Moore do not have property rights over any cells or tissues removed from their bodies that are used later to develop drugs or other commercial products. This case was the first in the nation to establish a legal precedent for the commercial development and use of human tissue. The National Organ Transplant Act of 1984 prevents the sale of human organs. Current laws allow the sale of human tissues and cells but do not define ownership interests of donors. Questions originally raised in the Moore case remain largely unresolved in laws and public policy. These questions are being raised in many other cases as well. Who owns fetal and adult stem-cell lines established from donors, and who has ownership of and a commercial interest in diagnostic tests developed through cell and tissue donations by affected individuals? Who benefits from new genetic technologies based on molecules, cells, or tissues contributed by patients? Are these financial, medical, and ethical benefits being distributed fairly? What can be done to ensure that risks and benefits are distributed in an equitable manner? Gaps between technology, laws, and public policy developed with the advent of recombinant DNA technology in the 1970s, and in the intervening decades, those gaps have not been closed. These controversies are likely to continue as new developments in technology continue to outpace social consensus about their use. Do you think that donors or patients who provide cells and/or tissues should retain ownership of their body parts or should share in any financial benefits that might derive from their use in research or commercial applications?arrow_forwardWho Owns Your Genome? John Moore, an engineer working on the Alaska oil pipeline, was diagnosed in the mid-1970s with a rare and fatal form of cancer known as hairy cell leukemia. This disease causes overproduction of one type of white blood cell known as a T lymphocyte. Moore went to the UCLA Medical Center for treatment and was examined by Dr. David Golde, who recommended that Moores spleen be removed in an attempt to slow down or stop the cancer. For the next 8 years, John Moore returned to UCLA for checkups. Unknown to Moore, Dr. Golde and his research assistant applied for and received a patent on a cell line and products of that cell line derived from Moores spleen. The cell line, named Mo, produced a protein that stimulates the growth of two types of blood cells that are important in identifying and killing cancer cells. Arrangements were made with Genetics Institute, a small start-up company, and then Sandoz Pharmaceuticals, to develop the cell line and produce the growth-stimulating protein. Moore found out about the cell line and its related patents and filed suit to claim ownership of his cells and asked for a share of the profits derived from the sale of the cells or products from the cells. Eventually, the case went through three courts, and in July 1990n years after the case beganthe California Supreme Court ruled that patients such as John Moore do not have property rights over any cells or tissues removed from their bodies that are used later to develop drugs or other commercial products. This case was the first in the nation to establish a legal precedent for the commercial development and use of human tissue. The National Organ Transplant Act of 1984 prevents the sale of human organs. Current laws allow the sale of human tissues and cells but do not define ownership interests of donors. Questions originally raised in the Moore case remain largely unresolved in laws and public policy. These questions are being raised in many other cases as well. Who owns fetal and adult stem-cell lines established from donors, and who has ownership of and a commercial interest in diagnostic tests developed through cell and tissue donations by affected individuals? Who benefits from new genetic technologies based on molecules, cells, or tissues contributed by patients? Are these financial, medical, and ethical benefits being distributed fairly? What can be done to ensure that risks and benefits are distributed in an equitable manner? Gaps between technology, laws, and public policy developed with the advent of recombinant DNA technology in the 1970s, and in the intervening decades, those gaps have not been closed. These controversies are likely to continue as new developments in technology continue to outpace social consensus about their use. Should the physicians at UCLA have told Mr. Moore that his cells and its products were being commercially developed?arrow_forwardDiscuss Concepts A forensic scientist obtained a small DNA sample from a crime scene. In order to examine the sample, he increased its quantity by cycling the sample through the polymerase chain reaction. He estimated that there were 50,000 copies of the DNA in his original sample. Derive a simple formula and calculate the number of copies he will have after15 cycles of the PCR.arrow_forward
- IPSCs are nearly identical to human embryonic stem cells in terms of gene expression, but there may be other ways in which they are not equivalent. For example, the telomeres of IPSCs often vary in length, with many IPSCs cells having telomeres shorter than those of embryonic. How might shortened telomeres affect the life-span of IPSCs or of differentiated cells derived from them?arrow_forwardGenetics Question about epigenetic mechanisms. This is the only question that I just do not understand. Which column does each of these go in and they can used multiple times or not at all.arrow_forwardUsing the figure below identify: What is the role of histones and nucleosomes? How the process of chromatin condensation is performed? What is a function of introns and exons? What is a role of mobile DNA elements? What is a meaning of simple-sequence DNA?arrow_forward
- Biology: The Dynamic Science (MindTap Course List)BiologyISBN:9781305389892Author:Peter J. Russell, Paul E. Hertz, Beverly McMillanPublisher:Cengage LearningHuman Heredity: Principles and Issues (MindTap Co...BiologyISBN:9781305251052Author:Michael CummingsPublisher:Cengage LearningBiology: The Unity and Diversity of Life (MindTap...BiologyISBN:9781305073951Author:Cecie Starr, Ralph Taggart, Christine Evers, Lisa StarrPublisher:Cengage Learning